IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,537,202 | +10.8% | 87,422 | +28.0% | 0.73% | +24.5% |
| Q2 2023 | $4,094,489 | +20.8% | 68,287 | -0.4% | 0.59% | +14.2% |
| Q1 2023 | $3,388,815 | -13.6% | 68,544 | -0.3% | 0.51% | -19.9% |
| Q4 2022 | $3,922,592 | +19.9% | 68,733 | -1.4% | 0.64% | +14.2% |
| Q3 2022 | $3,272,000 | -28.9% | 69,706 | -43.5% | 0.56% | -28.4% |
| Q2 2022 | $4,604,000 | -34.9% | 123,394 | -47.9% | 0.78% | -13.1% |
| Q1 2022 | $7,075,000 | -13.1% | 236,616 | -0.5% | 0.90% | +5.1% |
| Q4 2021 | $8,141,000 | +179.7% | 237,776 | +202.8% | 0.86% | +184.4% |
| Q3 2021 | $2,911,000 | – | 78,514 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |